• Treffer 2 von 2
Zurück zur Trefferliste

Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer’s Disease

Zitieren Sie bitte immer diese URN: urn:nbn:de:bvb:20-opus-197555
  • The cholinergic hypothesis has been reported first being the cause of memory dysfunction in the Alzheimer’s disease. Researchers around the globe have focused their attention on understanding the mechanisms of how this complicated system contributes to processes such as learning, memory, disorientation, linguistic problems, and behavioral issues in the indicated chronic neurodegenerative disease. The present review reports recent updates in hybrid molecule design as a strategy for selectively addressing multiple target proteins involved inThe cholinergic hypothesis has been reported first being the cause of memory dysfunction in the Alzheimer’s disease. Researchers around the globe have focused their attention on understanding the mechanisms of how this complicated system contributes to processes such as learning, memory, disorientation, linguistic problems, and behavioral issues in the indicated chronic neurodegenerative disease. The present review reports recent updates in hybrid molecule design as a strategy for selectively addressing multiple target proteins involved in Alzheimer’s disease (AD) and the study of their therapeutic relevance. The rationale and the design of the bifunctional compounds will be discussed in order to understand their potential as tools to investigate the role of the cholinergic system in AD.zeige mehrzeige weniger

Volltext Dateien herunterladen

Metadaten exportieren

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar Statistik - Anzahl der Zugriffe auf das Dokument
Metadaten
Autor(en): Daniela Volpato, Ulrike Holzgrabe
URN:urn:nbn:de:bvb:20-opus-197555
Dokumentart:Artikel / Aufsatz in einer Zeitschrift
Institute der Universität:Fakultät für Chemie und Pharmazie / Institut für Pharmazie und Lebensmittelchemie
Sprache der Veröffentlichung:Englisch
Titel des übergeordneten Werkes / der Zeitschrift (Englisch):Molecules
ISSN:1420-3049
Erscheinungsjahr:2018
Band / Jahrgang:23
Heft / Ausgabe:12
Seitenangabe:3230
Originalveröffentlichung / Quelle:Molecules 2018, 23(12), 3230; https://doi.org/10.3390/molecules23123230
DOI:https://doi.org/10.3390/molecules23123230
Allgemeine fachliche Zuordnung (DDC-Klassifikation):6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 615 Pharmakologie, Therapeutik
Freie Schlagwort(e):AChE inhibitor; Alzheimer’s disease; bitopic ligand; cholinergic system; hybrid molecules; muscarinic receptors; nicotinic receptors
Datum der Freischaltung:19.06.2020
Datum der Erstveröffentlichung:07.12.2018
Lizenz (Deutsch):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International